Table 2.
Cancer type11 | Least severe | Intermediate severity | Most severe |
Germ cell tumours | Stages 1–3; stage unknown. | Stage 4 (stage 1S=stage 4). | |
Leukaemias | CML. | ALL; other and unspecified. | AML. |
Non-Hodgkin’s lymphoma and non-specified lymphoma | Over 16 years, protocol unknown stage 1–2. | Over 16 s, protocol unknown; stage 3–4; any paediatric-type protocol; all unknown. | Burkitts (ICD-10 C83.7, morphology code 9687/3). |
Hodgkin’s lymphoma | All stages. | ||
Central nervous system tumours | Pituitary adenomas (D35.2); subependymal giant cell astrocytoma (C43.2). | Other completely resected WHO grade I tumours for which surgery is the only treatment needed, except craniopharyngiomas. | Craniopharyngiomas; incompletely resected or unresectable grade I tumours; all grade II–IV tumours, any needing radiotherapy or chemotherapy. This includes ependymomas, medulloblastomas and intracranial GCTs. |
Bone tumours | Surgery only (low grade, periosteal and parosteal). | All other. | |
Soft tissue sarcoma | Stages 1–2. | Stage 3; unknown. | Stage 4. |
Rhabdomyosarcoma | Low risk EpSSG A-D. | All others; unknown. | |
Melanoma | Stages 1–2 (except 2c). | Stage 2c; stage 3 (except 3c); stage unknown. | Stage 3c; stage 4. |
Carcinoma | All thyroid; all stage 1; Cervix stage unknown. | Stages 2–3; all nasopharyngeal; stage unknown (except cervix). | Stage 4. |
Miscellaneous and unspecified | All. |
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; EpSSG, European Paediatric Soft Tissue Sarcoma Study Group; GCT, germ cell tumours; ICD-10, International Classification of Diseases, 10th Revision.